Magnyl 1/1000IU Gonadatropin – Magnus

Magnyl 1/1000IU Gonadatropin – Magnus

Magnus Magnyl is a post‑cycle therapy (PCT) formulation designed to restore natural testosterone production after anabolic‑androgenic steroid use. The active ingredient, human chorionic gonadotropin (HCG), mimics luteinizing hormone (LH) and stimulates the testes to resume testosterone synthesis.

Key Benefits

• Strong stimulation of natural testosterone production
• Reduction of body fat levels while preserving muscle mass
• Support for sperm maturation and fertility
• Improvement in libido and sexual function
• Assistance in restoring testicular size and activity after suppression
• Clinical use in male infertility, delayed puberty, and underdeveloped gonads

Administration Guidelines

The recommended dosage for post‑cycle therapy is typically 1,000 IU per injection. Below is a common schedule used by athletes and bodybuilders:

In some protocols, the frequency is reduced to every other day after the first week. The injection site can be subcutaneous or intramuscular; follow a sterile technique and rotate sites.

Side Effects

• Water retention – may cause mild swelling or bloating
• Potential for gynecomastia if estrogen conversion is high
• Injection site reactions such as pain, redness, or irritation
• Hormonal fluctuations that could lead to mood changes or fatigue
• Rarely, allergic reactions; discontinue use and seek medical attention if severe symptoms occur

Clinical Applications Beyond Sports

In addition to its role in post‑cycle recovery, HCG is employed medically for:

• Treatment of male infertility and sperm production enhancement (often combined with follicle‑stimulating hormone)
• Management of delayed puberty in adolescent males
• Therapy for undescended testes or other gonadal developmental disorders

Availability at SynthesisGear

This product is sold exclusively by SynthesisGear, ensuring reliable sourcing and quality assurance for customers seeking post‑cycle support.